ReviewCommunications biology2026
Z-nucleic acid-mediated PANoptosis in infection, inflammation, and cancer.
Review in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immune response to DNA and RNA: structural insights, molecular mechanisms, and therapeutic targeting.Molecular biomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nucleic acids serve not only as carriers of genetic information but also as potent immunological signals that shape innate and adaptive immune responses. Their immunogenicity is determined by their origin, subcellular localization, structural conformation, and the host sensors that detect them. Within this landscape, Z-nucleic acids, including Z-RNA and Z-DNA, have emerged from biological noise to key regulators of immune activation, particularly through their ability to induce inflammatory cell death pathways. Both host and pathogens can generate Z-nucleic acids, yet the mechanisms governing their formation and regulation remain incompletely understood. In mammals, ZBP1 and ADAR1 are the only known Z-nucleic acid sensors, while some pathogens encode Z-binding proteins to evade detection. Although critical for host defense, dysregulated Z-nucleic acid signaling can drive autoimmunity and chronic inflammation. This review synthesizes current structural and functional principles of Z-nucleic acid recognition and highlights emerging therapeutic opportunities across infectious diseases, inflammatory disorders, and cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.